QY Research > レポート一覧 > メディカルケア > 体外膜肺酸素合世界市場の発展状況と動向 2024-2030

体外膜肺酸素合世界市場の発展状況と動向 2024-2030

英文タイトル: Global Extracorporeal Membrane Oxygenation (ECMO) Market Insights, Forecast to 2030

体外膜肺酸素合世界市場の発展状況と動向 2024-2030
  • レポートID:275729
  • 発表時期:2024-04-25
  • 訪問回数:279
  • ページ数:92
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:112
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は体外膜肺酸素合市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは体外膜肺酸素合の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の体外膜肺酸素合市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは体外膜肺酸素合のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に体外膜肺酸素合市場を分類しています。本研究に含まれる主な企業は:MAQUET、Microport、XENIOS、LivaNova、Medtronic、Terumo Cardiovascular、Nipro

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Veno-Arterial
Arterio-Venous
Veno-Venous

用途別の市場セグメント:
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)

レポートの詳細内容
世界の体外膜肺酸素合市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、体外膜肺酸素合タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の体外膜肺酸素合収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の体外膜肺酸素合市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、体外膜肺酸素合市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

体外膜肺酸素合のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:体外膜肺酸素合のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:体外膜肺酸素合の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3体外膜肺酸素合企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:体外膜肺酸素合の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:体外膜肺酸素合の主要企業の概要を提供し、製品の説明と仕様、体外膜肺酸素合の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Market Analysis and Insights: Global Extracorporeal Membrane Oxygenation (ECMO) Market
The global Extracorporeal Membrane Oxygenation (ECMO) market is projected to grow from US$ 297.5 million in 2024 to US$ 360 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period.
The US & Canada market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Extracorporeal Membrane Oxygenation (ECMO) include MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular and Nipro, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Extracorporeal Membrane Oxygenation (ECMO) is widely used in various fields, such as Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR),, etc. Respiratory provides greatest supports to the Extracorporeal Membrane Oxygenation (ECMO) industry development. In 2023, global % revenue of Extracorporeal Membrane Oxygenation (ECMO) went into Respiratory filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Extracorporeal Membrane Oxygenation (ECMO) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Extracorporeal Membrane Oxygenation (ECMO), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Extracorporeal Membrane Oxygenation (ECMO), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Extracorporeal Membrane Oxygenation (ECMO) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Extracorporeal Membrane Oxygenation (ECMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Extracorporeal Membrane Oxygenation (ECMO) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular and Nipro, etc.

Market Segmentation
By Company
    MAQUET
    Microport
    XENIOS
    LivaNova
    Medtronic
    Terumo Cardiovascular
    Nipro

Segment by Type
    Veno-Arterial
    Arterio-Venous
    Veno-Venous

Segment by Application
    Respiratory
    Cardiac
    Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Extracorporeal Membrane Oxygenation (ECMO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Extracorporeal Membrane Oxygenation (ECMO) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Veno-Arterial
1.2.3 Arterio-Venous
1.2.4 Veno-Venous
1.3 Market by Application
1.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Respiratory
1.3.3 Cardiac
1.3.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Perspective (2019-2030)
2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Growth Trends by Region
2.2.1 Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Region (2019-2024)
2.2.3 Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Region (2025-2030)
2.3 Extracorporeal Membrane Oxygenation (ECMO) Market Dynamics
2.3.1 Extracorporeal Membrane Oxygenation (ECMO) Industry Trends
2.3.2 Extracorporeal Membrane Oxygenation (ECMO) Market Drivers
2.3.3 Extracorporeal Membrane Oxygenation (ECMO) Market Challenges
2.3.4 Extracorporeal Membrane Oxygenation (ECMO) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Extracorporeal Membrane Oxygenation (ECMO) by Players
3.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Revenue by Players (2019-2024)
3.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Market Share by Players (2019-2024)
3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Extracorporeal Membrane Oxygenation (ECMO), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Extracorporeal Membrane Oxygenation (ECMO) Market Concentration Ratio
3.4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracorporeal Membrane Oxygenation (ECMO) Revenue in 2023
3.5 Global Key Players of Extracorporeal Membrane Oxygenation (ECMO) Head office and Area Served
3.6 Global Key Players of Extracorporeal Membrane Oxygenation (ECMO), Product and Application
3.7 Global Key Players of Extracorporeal Membrane Oxygenation (ECMO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Extracorporeal Membrane Oxygenation (ECMO) Breakdown Data by Type
4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Type (2019-2024)
4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Type (2025-2030)

5 Extracorporeal Membrane Oxygenation (ECMO) Breakdown Data by Application
5.1 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Application (2019-2024)
5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
6.2 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
6.2.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024)
6.2.2 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030)
6.2.3 North America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
6.3 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
6.3.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024)
6.3.2 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030)
6.3.3 North America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
6.4 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country
6.4.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
6.4.3 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
7.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
7.2.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024)
7.2.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030)
7.2.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
7.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
7.3.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024)
7.3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030)
7.3.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
7.4 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country
7.4.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
7.4.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
8.2 China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
8.2.1 China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024)
8.2.2 China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030)
8.2.3 China Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
8.3 China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
8.3.1 China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024)
8.3.2 China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030)
8.3.3 China Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
9.2 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
9.2.1 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024)
9.2.2 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030)
9.2.3 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
9.3 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
9.3.1 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024)
9.3.2 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030)
9.3.3 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
9.4 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region
9.4.1 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2019-2024)
9.4.3 Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 MAQUET
11.1.1 MAQUET Company Details
11.1.2 MAQUET Business Overview
11.1.3 MAQUET Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.1.4 MAQUET Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.1.5 MAQUET Recent Developments
11.2 Microport
11.2.1 Microport Company Details
11.2.2 Microport Business Overview
11.2.3 Microport Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.2.4 Microport Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.2.5 Microport Recent Developments
11.3 XENIOS
11.3.1 XENIOS Company Details
11.3.2 XENIOS Business Overview
11.3.3 XENIOS Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.3.4 XENIOS Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.3.5 XENIOS Recent Developments
11.4 LivaNova
11.4.1 LivaNova Company Details
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.4.4 LivaNova Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.4.5 LivaNova Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.5.4 Medtronic Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.5.5 Medtronic Recent Developments
11.6 Terumo Cardiovascular
11.6.1 Terumo Cardiovascular Company Details
11.6.2 Terumo Cardiovascular Business Overview
11.6.3 Terumo Cardiovascular Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.6.4 Terumo Cardiovascular Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.6.5 Terumo Cardiovascular Recent Developments
11.7 Nipro
11.7.1 Nipro Company Details
11.7.2 Nipro Business Overview
11.7.3 Nipro Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.7.4 Nipro Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.7.5 Nipro Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Veno-Arterial
    Table 3. Key Players of Arterio-Venous
    Table 4. Key Players of Veno-Venous
    Table 5. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Region (2019-2024)
    Table 9. Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Region (2025-2030)
    Table 11. Extracorporeal Membrane Oxygenation (ECMO) Market Trends
    Table 12. Extracorporeal Membrane Oxygenation (ECMO) Market Drivers
    Table 13. Extracorporeal Membrane Oxygenation (ECMO) Market Challenges
    Table 14. Extracorporeal Membrane Oxygenation (ECMO) Market Restraints
    Table 15. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Share by Players (2019-2024)
    Table 17. Global Top Extracorporeal Membrane Oxygenation (ECMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Membrane Oxygenation (ECMO) as of 2023)
    Table 18. Global Extracorporeal Membrane Oxygenation (ECMO) Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Extracorporeal Membrane Oxygenation (ECMO) Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Extracorporeal Membrane Oxygenation (ECMO), Headquarters and Area Served
    Table 21. Global Key Players of Extracorporeal Membrane Oxygenation (ECMO), Product and Application
    Table 22. Global Key Players of Extracorporeal Membrane Oxygenation (ECMO), Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Market Share by Type (2019-2024)
    Table 26. Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Market Share by Type (2025-2030)
    Table 28. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Share by Application (2019-2024)
    Table 30. Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Share by Application (2025-2030)
    Table 32. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Extracorporeal Membrane Oxygenation (ECMO) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Extracorporeal Membrane Oxygenation (ECMO) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Extracorporeal Membrane Oxygenation (ECMO) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030) & (US$ Million)
    Table 64. MAQUET Company Details
    Table 65. MAQUET Business Overview
    Table 66. MAQUET Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 67. MAQUET Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 68. MAQUET Recent Developments
    Table 69. Microport Company Details
    Table 70. Microport Business Overview
    Table 71. Microport Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 72. Microport Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 73. Microport Recent Developments
    Table 74. XENIOS Company Details
    Table 75. XENIOS Business Overview
    Table 76. XENIOS Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 77. XENIOS Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 78. XENIOS Recent Developments
    Table 79. LivaNova Company Details
    Table 80. LivaNova Business Overview
    Table 81. LivaNova Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 82. LivaNova Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 83. LivaNova Recent Developments
    Table 84. Medtronic Company Details
    Table 85. Medtronic Business Overview
    Table 86. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 87. Medtronic Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 88. Medtronic Recent Developments
    Table 89. Terumo Cardiovascular Company Details
    Table 90. Terumo Cardiovascular Business Overview
    Table 91. Terumo Cardiovascular Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 92. Terumo Cardiovascular Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 93. Terumo Cardiovascular Recent Developments
    Table 94. Nipro Company Details
    Table 95. Nipro Business Overview
    Table 96. Nipro Extracorporeal Membrane Oxygenation (ECMO) Product
    Table 97. Nipro Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024) & (US$ Million)
    Table 98. Nipro Recent Developments
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type: 2023 VS 2030
    Figure 3. Veno-Arterial Features
    Figure 4. Arterio-Venous Features
    Figure 5. Veno-Venous Features
    Figure 6. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application: 2023 VS 2030
    Figure 8. Respiratory Case Studies
    Figure 9. Cardiac Case Studies
    Figure 10. Extracorporeal Cardiopulmonary Resuscitation (ECPR) Case Studies
    Figure 11. Extracorporeal Membrane Oxygenation (ECMO) Report Years Considered
    Figure 12. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Extracorporeal Membrane Oxygenation (ECMO) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Region: 2023 VS 2030
    Figure 15. Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Players in 2023
    Figure 16. Global Top Extracorporeal Membrane Oxygenation (ECMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Membrane Oxygenation (ECMO) as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Extracorporeal Membrane Oxygenation (ECMO) Revenue in 2023
    Figure 18. North America Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
    Figure 20. North America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
    Figure 21. North America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Country (2019-2030)
    Figure 22. United States Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
    Figure 26. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
    Figure 27. Europe Extracorporeal Membrane Oxygenation (ECMO) Market Share by Country (2019-2030)
    Figure 28. Germany Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
    Figure 36. China Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
    Figure 37. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
    Figure 39. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
    Figure 40. Asia Extracorporeal Membrane Oxygenation (ECMO) Market Share by Region (2019-2030)
    Figure 41. Japan Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Share by Country (2019-2030)
    Figure 51. Brazil Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Extracorporeal Membrane Oxygenation (ECMO) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. MAQUET Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 58. Microport Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 59. XENIOS Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 60. LivaNova Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 61. Medtronic Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 62. Terumo Cardiovascular Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 63. Nipro Revenue Growth Rate in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)